Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 4980-4987, Vol. 69, No. 8
Department of Pathology, University of
California, San Diego, La Jolla, California,1
and Departments of Medicine, Pathology, and Microbiology,
University of Colorado Health Sciences Center,
Denver,2 and Department of
Microbiology, Colorado State University, Fort
Collins,3 Colorado
Received 15 December 2000/Returned for modification 15 January
2001/Accepted 1 May 2001
Macrophages produce reactive oxygen species and reactive nitrogen
species that have potent antimicrobial activity. Resistance to killing
by macrophages is critical to the virulence of
Mycobacterium tuberculosis. M. tuberculosis has two
genes encoding superoxide dismutase proteins, sodA and
sodC. SodC is a Cu,Zn superoxide dismutase responsible
for only a minor portion of the superoxide dismutase activity of
M. tuberculosis. However, SodC has a lipoprotein binding
motif, which suggests that it may be anchored in the membrane to
protect M. tuberculosis from reactive oxygen
intermediates at the bacterial surface. To examine the role of the
Cu,Zn superoxide dismutase in protecting M.
tuberculosis from the toxic effects of exogenously generated
reactive oxygen species, we constructed a null mutation in the
sodC gene. In this report, we show that the
M. tuberculosis sodC mutant is readily killed by
superoxide generated externally, while the isogenic parental
M. tuberculosis is unaffected under these
conditions. Furthermore, the sodC mutant has enhanced
susceptibility to killing by gamma interferon (IFN- The virulence of Mycobacterium
tuberculosis is dependent upon the establishment of an infection
within human macrophages. Reactive oxygen species (ROS) and
reactive nitrogen species (RNS) are produced by macrophages as
part of their antimicrobial response. The production of ROS is
initiated by NADPH oxidase, which catalyzes the reduction of molecular
oxygen to superoxide (O2 Despite the toxic effects of ROS and RNS, M. tuberculosis can survive and grow within macrophages.
Several M. tuberculosis gene products have been
associated with the detoxification of ROS and RNS. KatG is a catalase
peroxidase (32) that protects M. tuberculosis from killing by hydrogen peroxide (26).
KatG also has peroxynitritase activity (40). The
alkylhydroperoxide reductase AhpC is capable of catalyzing the
breakdown of peroxynitrite (5). Lipoarabinomannan can
scavenge potentially toxic oxygen free radicals (8).
M. tuberculosis also produces two superoxide dismutase
(SOD) proteins, SodA and SodC. The enzymatic function of SOD is to
convert O2 Because of the location of SodC on the surface of the bacteria, we
examined the role of the Cu,Zn SOD in protecting M. tuberculosis from exogenous sources of ROS. A mutation in the
sodC gene was constructed, and the M. tuberculosis mutant was used to assess the importance of SodC in
protecting M. tuberculosis from the toxic effects of
superoxide or a combination of superoxide and nitric oxide generated in
vitro. In addition, we evaluated the contribution of the
sodC gene to the survival of M. tuberculosis in macrophages. In this report, we show that the
sodC gene of M. tuberculosis is necessary
for resistance to killing by exogenously generated superoxide and toxic
synergistic products of superoxide with RNS. Furthermore, Cu,Zn SOD
contributes to survival of M. tuberculosis in gamma
interferon (IFN- Bacterial strains and growth conditions.
The bacterial
strains used in this study included M. tuberculosis
strain Erdman (ATCC 35801), Mycobacterium bovis El Paso, Mycobacterium africanum, Mycobacterium microti,
M. bovis BCG Pasteur, Mycobacterium
gordonii, Mycobacterium xenopi, Mycobacterium smegmatis (ATCC 607), Mycobacterium chelonae subsp.
chelonae (ATCC 35752), Mycobacterium fortuitum
subsp. peregrinum (ATCC 14467), Mycobacterium kansasii (clinical isolate), Mycobacterium scrofulaceum
(clinical isolate), Mycobacterium marinum (ATC 927),
Mycobacterium avium (clinical isolate), and
Mycobacterium intracellulare (clinical isolate).
Bacteria were grown in Middlebrook 7H9 medium supplemented with
albumin-dextrose complex (ADC) and 0.05% Tween 80 (20). Hygromycin (50 µg/ml) and kanamycin (25 µg/ml)
were added during the selection for the sodC mutant. Growth
of bacteria was measured by monitoring the optical density at 580 nm
(OD580) in triplicate cultures.
Construction of a sodC mutant of M.
tuberculosis.
The sodC gene of M. tuberculosis was cloned from cosmid Y22G10, which was obtained
from S. Cole (9). A 4.3-kb ClaI restriction fragment containing the 719-bp sodC gene flanked by 1.1 and
2.6 kb of DNA was subcloned into pBluescript KS (Stratagene) using standard protocols (33). The sodC gene was
disrupted by cloning a 2.7-kb cassette containing the genes for
resistance to kanamycin (aph) and to hygromycin
(hyg) into the MluI site within the
sodC gene (Fig. 1A.). DNA containing the
disrupted sodC gene was linearized and electroporated into
M. tuberculosis Erdman. Transformants were selected on
7H11 plates containing both kanamycin and hygromycin. Transformants
that had undergone homologous recombination within the sodC
gene were identified by Southern hybridization using probes
corresponding to the genes for sodC and aph
(6). One of the sodC mutants was designated
Mtb1612 and was used in these studies.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4980-4987.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cu,Zn Superoxide Dismutase of Mycobacterium
tuberculosis Contributes to Survival in Activated
Macrophages That Are Generating an Oxidative Burst
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
)-activated murine peritoneal macrophages producing oxidative burst
products but is unaffected by macrophages not activated by
IFN-
or by macrophages from respiratory burst-deficient
mice. These observations establish that the Cu,Zn superoxide dismutase
contributes to the resistance of M. tuberculosis
against oxidative burst products generated by activated macrophages.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
).
Superoxide can then be converted to
H2O2 and hydroxyl radical (27). In addition, nitric oxide (NO) produced by inducible
nitric oxide synthase (iNOS) can combine with superoxide to generate additional products with enhanced toxicity, such as peroxynitrite (ONOO
) (4).
into molecular
oxygen and hydrogen peroxide. This activity removes the toxic effects
of O2
and prevents the
formation of higher H2O2
levels by other reactions (39) and the synergism of ROS
with RNS (25, 39). SodA is an Mn,Fe SOD and is one of
the major extracellular proteins in M. tuberculosis
(18, 44). SodC is a Cu,Zn SOD and is produced at much
lower levels by M. tuberculosis. However, SodC contains a lipoprotein binding motif that may mediate its attachment to the
outer membrane of the bacteria. Immunogold electron microscopy has
detected SodC at the periphery of M. tuberculosis
(42). The peripheral location of the Cu,Zn SOD suggests
that it may protect the surface of M. tuberculosis
against extracellular superoxide generated by host cells.
)-activated macrophages that are producing
an oxidative burst.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (27K):
[in a new window]
FIG. 1.
(A) Restriction map of the sodC region in
parental and sodC mutant strains of M.
tuberculosis. (B) Southern blot of chromosomal DNAs from the
parental, mutant, and complemented strains. DNA was digested with
EcoRV and probed with DNA containing the gene for
sodC or for aph. The
sodC-hybridizing fragment in mutant Mtb1612 is larger
than the unmutated fragment due to insertion of the drug resistance
cassette. This fragment also hybridizes with the aph
probe, confirming that Mtb1612 contains the kanamycin resistance gene
that produced the mutation.
Complementation of the sodC mutant. To genetically complement the sodC mutant, a wild-type copy of the sodC gene was introduced into the sodC mutant Mtb1612 using the integrative vector pCV125 (a gift from MedImmune) (6). A PCR fragment carrying the complete coding sequence of the sodC gene was amplified from M. tuberculosis Erdman DNA using forward primer 5'TTGATATCTTTGATAAACGCCAGGTTAGCTCTC3' and reverse primer 5'TACTAGTTTATCACTAGCCGGAACCAATGAC3'. The forward primer contains an NruI restriction site, two stop codons, and the sequence immediately upstream of the sodC start codon. The reverse primer corresponds to the 3' end of the sodC gene with an additional stop codon and an SpeI restriction site. The sodC PCR fragment was digested with NruI and SpeI and cloned between the NruI and SpeI sites in pCV125 (Sp/Sm). The sodC gene in this vector is transcribed from the aph promoter. DNA sequencing confirmed that no mutations were present in the PCR-amplified sodC gene compared to the published sequence (9). pCV125 (Sp/Sm)::sodC was electroporated into the sodC mutant Mtb1612, and transformants were selected on 7H11 plates containing streptomycin (30 µg/ml). As a control, plasmid pCV125 was electroporated into additional preparations of Mtb1612. Integration of pCV125::sodC into the chromosome of Mtb1612 was confirmed by Southern hybridization.
In vitro superoxide and nitric oxide susceptibility assays. In vitro superoxide killing assays were performed using a hypoxanthine/xanthine oxidase system to generate superoxide (11). Mid-log-phase cultures of bacteria grown in 7H9 medium were washed and adjusted to a density of approximately 106 CFU/ml. Bacteria were exposed to superoxide generated by combining 250 µM hypoxanthine with 0.1 U of xanthine oxidase (Sigma) per ml in phosphate-buffered saline. Catalase (1 U/ml) was added to prevent killing by H2O2 during the assay. Percent survival was determined at 0, 1, and 3 h postexposure by plating serial dilutions of the bacteria on 7H10 plates. The means from triplicate tubes were calculated, and the data were expressed as a percentage of the value at time zero. Sensitivity to nitric oxide was tested using 1 mM 2,2'-(hydroxynitrosohydrazono)bisethanamine prepared in NaOH (SPER/NO; Alexis Biochemicals, San Diego, Calif.) (11). NO is generated from this compound under slightly basic conditions. The NO assays were carried out in a manner similar to that described for the superoxide assays. To test for sensitivity to synergistic interactions of ROS and RNS, superoxide and nitric oxide were generated in the same tubes (11).
Macrophage killing assays.
Mouse peritoneal
macrophages were used for these studies because they can be
stimulated to produce significant quantities of both ROS and RNS in
vitro. Cells were harvested from C57BL/6 mice (Jackson Laboratories) to
obtain macrophages that produce a respiratory burst or from
gp91phox
/
mice (C57BL/6) or
iNOS
/
mice (C57BL/6) to obtain
macrophages defective in the production of ROS
(31) or RNS (24). Macrophages were elicited
by injection of 1 ml of 5 mM sodium periodate into the peritoneal
cavity (11). After 4 days, mice were sacrificed and
macrophages were harvested by peritoneal lavage. Macrophages
(2 × 105 per well) were seeded in wells of
a 48-well plate and were incubated overnight with murine recombinant
IFN-
(100 U/ml). Macrophages were infected with wild-type
M. tuberculosis, the sodC mutant (Mtb1612),
or the sodC-complemented strain (Mtb1623) at a multiplicity of infection of 10:1. Bacteria were opsonized by incubation with normal
mouse serum for 30 min at 37°C prior to infection. After the addition
of bacteria, the cells were incubated at 37°C for 1 h to allow
the bacteria to be phagocytized. Nonadherent bacteria were removed by
being washed three times with RPMI plus 2% fetal calf serum. After
washing, fresh RPMI with 10% fetal calf serum was added and the
cultures were further incubated. Macrophages were lysed at 0, 2, 6, 24, and 36 h, and numbers of surviving intracellular bacteria were
determined by plating on 7H10 medium (6). Data are
expressed as means and standard errors of the means from triplicate
(C57BL/6 and gp91phox
/
) or
quadruplicate (iNOS
/
) wells at each time point.
Detection of ROS and RNS.
The production of ROS and RNS was
measured in macrophages from C57BL/6 mice used in the
macrophage killing assays. Macrophages (2.5 × 105 per well) were seeded in wells of a 48-well
plate and were incubated overnight with murine recombinant IFN-
(100 U/ml). Macrophages were either infected with wild-type M. tuberculosis as described above, stimulated with phorbol myristate
acetate (PMA) (100 ng/ml), or left unstimulated. The production of
superoxide was quantified by detecting the reduction of nitroblue
tetrazolium (NBT) within the macrophages (1). For
each measurement, culture medium was removed from triplicate wells of
macrophages, 0.5 ml of 0.1% NBT in phosphate-buffered saline
was added to each well, and the cells were incubated at 37°C for 15 min. The NBT solution was then removed, and the cells were resuspended
in 1 ml of dimethyl sulfoxide to solubilize the formazan precipitate
that resulted from the reduction of NBT. Formazan amounts were
quantitated by measuring the optical density at 570 nm against a
dimethyl sulfoxide reference. Triplicate samples were examined at 0, 2, 6, 24, and 36 h posttreatment in two independent experiments, and
the values were then combined and expressed as the mean and standard
error of the mean.
Southern hybridization analysis. Southern blot analysis was carried out as previously described (6). Briefly, chromosomal DNA was digested with NotI, electrophoresed through 0.8% agarose gels, and transferred overnight onto a nylon membrane. The membrane was probed with the entire open reading frame of the sodC gene which had been amplified by PCR from M. tuberculosis Erdman DNA.
| |
RESULTS |
|---|
|
|
|---|
Construction of a sodC mutant of M. tuberculosis. To evaluate whether the Cu,Zn SOD is essential for the protection of M. tuberculosis from the toxic effects of ROS and from killing by macrophages, we constructed an M. tuberculosis mutant defective in the sodC gene. In sodC mutant Mtb1612, the sodC gene has been disrupted by the insertion of the aph and hyg genes (Fig. 1A.). This additional DNA increases the size of the sodC-containing fragment, as shown in Fig. 1B. A similar-sized fragment hybridizes with the aph probe, confirming that the sodC mutant contains the kanamycin resistance gene that produced the mutation (Fig. 1B.). The sodC-complemented strain (Mtb1623) carries both a mutated copy and a wild-type copy of sodC (Fig. 1B).
The sodC mutant of M.
tuberculosis grows normally in 7H9 medium.
Toxic ROS are
generated within cells during aerobic respiration (27). To
address whether SodC is essential for maintaining normal growth of
M. tuberculosis in laboratory medium, we compared growth of parental M. tuberculosis with that of the
sodC mutant in 7H9 broth. Cultures were grown at 37°C in
an atmosphere of 19 to 20% O2 and 5%
CO2 and were monitored for 30 days by reading the
OD580. As shown in Fig. 2, the
sodC mutant exhibited no defect in growth under these
conditions.
|
The M. tuberculosis sodC mutant is sensitive to
superoxide-dependent killing.
The sensitivity of the
sodC mutant to superoxide was tested using
hypoxanthine/xanthine oxidase to generate superoxide externally (11). Following a 3-h exposure to superoxide, there was
greater than a 90% decrease in survival of the sodC mutant
(Fig. 3A). The majority of this killing took place
during the first hour of exposure to superoxide. Sensitivity of the
sodC mutant to superoxide was significantly greater than
that of parental M. tuberculosis, which declined in
viability by 15% over the 3-h period. In the sodC-complemented strain, resistance to superoxide was
restored to levels slightly higher than in parental M. tuberculosis. The higher level of resistance in the complemented
strain may be due to differences in levels of expression of the
sodC gene in these two strains. In the complemented strain,
the sodC gene is expressed from the aph promoter,
whereas in the parental strain, sodC is expressed from its
own promoter.
|
Cu,Zn SOD contributes to the survival of M.
tuberculosis in macrophages that are generating an
oxidative burst.
Production of ROS and RNS by macrophages
is a major component in the host's antimicrobial defense. To determine
if Cu,Zn SOD contributes to the resistance of M. tuberculosis to killing by macrophages, survival of the
sodC mutant after phagocytosis by macrophages was
assessed. Murine peritoneal macrophages were used in these
assays because they can be stimulated to produce large amounts of ROS
and NOS in vitro. Although human macrophages produce both ROS
and RNS in vivo, human macrophages in general produce lower
levels of RNS in vitro (29) and are thus less informative for in vitro studies to examine the effect of RNS. Macrophages from phagocyte oxidase-deficient mice
(gp91phox
/
) were used to identify
intracellular killing that was dependent upon the generation of ROS.
Macrophages deficient in the iNOS gene
(iNOS
/
) were used to examine killing that was
dependent upon RNS production. Macrophages were elicited with sodium
periodate, which activates the cells to produce both ROS and RNS
(12). A portion of the macrophages were further
activated by incubation with IFN-
for 20 h prior to infection.
In macrophages not activated with IFN-
, we observed no
killing with any of the bacterial strains (data not shown). Therefore,
all further experiments were performed with IFN-
-activated cells.
There was significant killing of the sodC mutant in
macrophages from C57BL/6 mice (Fig. 4A). By
6 h after infection, there was a 43% decrease in survival of the
sodC mutant, while the numbers of parental M. tuberculosis cells and the sodC-complemented mutant
cells declined only slightly. Sensitivity of the sodC mutant
to killing by macrophages was abolished in cells from phagocyte
oxidase-deficient mice (gp91phox
/
)
(Fig. 4B), indicating that killing of the sodC mutant was
due to the oxidative burst. Interestingly, overall killing of the sodC mutant in the iNOS-deficient macrophages was
similar to killing in the normal macrophages, with a 46%
decrease in viability at 6 h (Fig. 4C). This suggests that the
sodC mutant was not exposed to synergistic products formed
by the interaction of ROS with RNS during the in vitro
macrophage assay.
|
|
The sodC gene is present in most mycobacterial
species.
To evaluate the distribution of the sodC gene
in mycobacterial species other than M. tuberculosis,
chromosomal DNAs from 15 mycobacterial species were probed with the
sodC gene from M. tuberculosis. By Southern
blot analysis, the sodC gene was detected in the majority of
mycobacteria assayed. These include members of the tuberculosis complex
(M. tuberculosis [Erdman], M. africanum, M. bovis, M. microti,
and M. bovis BCG) (Fig. 5, lanes
1 to 5), two of three rapid-growing species of mycobacteria
(M. fortuitum and M. smegmatis) (Fig.
5, lanes 6 and 8), and seven slow-growing mycobacteria
(M. xenopi, M. gordonae, M. marinum, M. scrofulaceum, M. kansasii, M. intracellulare, and M. avium) (Fig. 5, lanes 9 to 15). A sodC-hybridizing sequence was not detected in M. chelonae in two
different preparations of DNA. Thus, it appears that the
sodC gene is widely distributed among mycobacteria.
|
| |
DISCUSSION |
|---|
|
|
|---|
The phagocyte respiratory burst is important for controlling infections caused by many pathogens, as evidenced by clinical observations of patients with chronic granulomatous disease (28). This is true for mycobacterial infections, including BCG and M. tuberculosis, which exhibit an increased incidence in chronic granulomatous disease patients (19, 23, 28). In addition, experiments performed with phagocyte oxidase knockout mice have established that the respiratory burst of the host contributes to the control of M. tuberculosis during experimental infections (2, 10). However, M. tuberculosis can persist in the macrophage despite the activity of the macrophage NADPH oxidase and iNOS, indicating that M. tuberculosis has defenses to protect it from the toxic effects of ROS and RNS.
In this report, we establish that Cu,Zn SOD of M. tuberculosis is protective against the toxic effects of superoxide
generated by hypoxanthine/xanthine oxidase and contributes to
resistance to killing by oxidative products generated by activated
macrophages. Recently it was reported that Cu,Zn SOD mutants of
M. tuberculosis and of BCG are only moderately
sensitive to superoxide generated in vitro using the
superoxide-generating agent menadione or plumbagin and that the BCG
sodC mutant was unaffected in activated murine bone marrow
macrophages or in guinea pig tissues (13).
Although differences in methodology make it difficult to compare the
present data and results in the previous report, the sodC
mutant appears to have greater sensitivity to superoxide that is
generated extracellularly using hypoxanthine/xanthine oxidase.
Both plumbagin and menadione are known to increase intracellular levels
of superoxide (3, 15, 21). If the Cu,Zn SOD protects the
surface of the bacteria from externally generated superoxide, the
influence of a sodC mutation is expected to be more
pronounced when an extracellular superoxide-generating agent such as
hypoxanthine/xanthine oxidase is used. We also predict that the
contribution of the Cu,Zn SOD to survival of M. tuberculosis in macrophages is dependent upon the quantity
of ROS generated. In our study, murine peritoneal macrophages
activated with IFN-
were used because they produce large amounts of
ROS in response to infection. In previous studies, we have noted
that bone marrow-derived macrophages produce a less robust
oxidative burst than peritoneal macrophages. In the present study, the sodC mutant was sensitive to killing by
peritoneal macrophages from normal mice, and this sensitivity
was abolished in peritoneal macrophages from
gp91phox
/
mice. These results indicate
that Cu,Zn SOD contributes to the resistance of M. tuberculosis to phagocyte-derived oxidative burst products.
Inactivation by macrophages of the sodC mutant corresponded with the initial detection of superoxide production in these cells. From the kinetics of inactivation of the sodC mutant in macrophages, it appears that the initial interaction with superoxide is most critical in determining whether the mutant bacteria are killed. After the first 6 h of infection, we observed significantly less death of the sodC mutant even though elevated levels of superoxide were detected in the macrophages. Possible reasons for this later stabilization of sodC mutant viability are alterations in the sensitivity of the bacteria to superoxide during the later stages of infection due to changes in expression of other gene products or changes in the localization of ROS products during infection. These questions will be addressed in future studies
In concert with the phagocyte respiratory burst, macrophages generate toxic NOS. Synergism between the NADPH oxidase and iNOS pathways generate products with enhanced toxicity. Peroxynitrite as well as other synergistic intermediates formed by the reaction of ROS with nitric oxide have potent antimicrobial activity (29, 30). In our studies, parental M. tuberculosis was resistant to a combination of superoxide and nitric oxide when generated in vitro. This is consistent with a previous report that virulent M. tuberculosis is relatively resistant to peroxynitrite (43). The sodC mutant was, however, extremely sensitive in vitro to a combination of superoxide and nitric oxide. Despite this sensitivity in vitro, inactivation of the sodC mutant was unchanged in iNOS-deficient macrophages compared to normal macrophages. We also cultured macrophages from wild-type mice in medium deficient in L-arginine, which prevents the production of RNS, and did not observe a change in virulence of the sodC mutant (data not shown). Therefore, it appears that the production of RNS does not contribute to killing of the sodC mutant during the in vitro macrophage assay. This corresponds with our observations that the production of NO by the M. tuberculosis-infected macrophages does not occur until after killing of the sodC mutant has subsided and that there is no additional inactivation of the mutant with the appearance of NO at 24 h. It is clear that the simultaneous addition of exogenous superoxide and nitric oxide has different consequences for the sodC mutant than exposure to these products by macrophages cultured in vitro. Presumably, the kinetics for production of superoxide and nitric oxide in vivo may be different from those in our macrophage system, as activation of both the NADPH oxidase and the iNOS is dependent on the complex cytokine response generated by M. tuberculosis infection.
Cu,Zn SOD genes have been detected in a number of other bacteria, including Haemophilus (34), Neisseria (41), Escherichia (17), Legionella (36), and Salmonella (7). In some pathogenic bacteria, such as Neisseria meningitidis (41), Salmonella enterica serovar Typhimurium (11, 16), and Haemophilus ducreyi (34), the Cu,Zn SOD has been associated with virulence. In fact, virulent strains of Salmonella produce two distinct Cu,Zn SODs, each of which contributes to the virulence of Salmonella (14). In other pathogenic bacteria, an association of the Cu,Zn SOD with virulence is unclear. In the swine pathogen Actinobacillus pleuropneumoniae, a sodC mutant was not attenuated after intratracheal infection (35), and one of two studies using a sodC mutant of Brucella abortus found no attenuation of the mutant (22, 38). This suggests that the role of Cu,Zn SOD during infection may depend upon a variety of factors, including the infecting organism, host, route of acquisition, and site of infection.
In addition to the Cu,Zn SOD, M. tuberculosis carries an Mn,Fe SOD, SodA. Interestingly, SodA is one of the major secreted proteins of M. tuberculosis (44). We observed a disproportionate production of SodA versus SodC on SOD activity gels, making it impossible to visualize SodC activity in this manner (data not shown). Although SodC is produced in much smaller amounts than SodA, the phenotype of the M. tuberculosis sodC mutant was very dramatic in the in vitro assays. Thus, despite the presence of large amounts of SodA, Cu,Zn SOD is essential for protecting M. tuberculosis from the toxic effects of superoxide.
The Cu,Zn SOD may serve another function for mycobacteria in addition to protecting the bacteria from ROS generated by activated macrophages. The sodC gene was detected in 14 out of 15 mycobacterial species, which include rapid growers and nonpathogenic species. This suggests that the sodC gene product may play a role in detoxifying superoxide during growth of bacteria outside the host. Although we detected no defect in growth of the sodC mutant during culture in 7H9 broth, the Cu,Zn SOD may protect the bacteria from endogenously generated superoxide under specialized conditions. Gort et al. have suggested that the Cu,Zn SOD of Escherichia coli plays a role in protecting the bacteria from endogenously produced superoxide generated during specific phases in the growth cycle, such as the transition into stationary phase (17). Cu,Zn SOD may fulfill a similar role in mycobacteria.
This report demonstrates that Cu,Zn SOD of M. tuberculosis is protective against extracellular superoxide and
against a combination of superoxide and nitric oxide.
Furthermore, sodC mutant M. tuberculosis has increased sensitivity to hydrogen peroxide
compared to the isogenic parental strain (data not shown). These
results support the hypothesis that the Cu,Zn SOD protects
M. tuberculosis from extracellular sources of ROS.
However, despite the contribution of SodC to survival in
macrophages in vitro, a preliminary study using low-dose
aerosol infection suggests that the sodC gene is not
essential for survival of M. tuberculosis in the lungs
of mice during early stages of infection (data not shown). In this initial study, no difference in bacterial numbers between parental M. tuberculosis and the sodC mutant was
observed in the lung up to 60 days postinfection. At 60 days, a slight
difference in organism burden in the lungs was noted. This may indicate
that in the absence of SodC, SodA is capable of protecting the bacteria
from superoxide generated during the early stages of pulmonary
infection. While performing the macrophage assays, we observed
that sodC mutant M. tuberculosis was
sensitive to killing by macrophages only when the
macrophages were activated with IFN-
. In nonactivated
macrophages, which produce a less vigorous oxidative burst, the
phenotype of the sodC mutant was lost. This suggests that a
major role for the Cu,Zn SOD is to protect M. tuberculosis from large quantities of toxic reactive products
produced by activated macrophages. During the early stages of
infection, the lower levels of respiratory burst products generated by
nonactivated macrophages may not require the presence of Cu,Zn
SOD. Future experiments will evaluate the contribution of Cu,Zn SOD to
M. tuberculosis infections in a long-term in vivo study.
In conclusion, we have established that M. tuberculosis Cu,Zn SOD is required for resistance to exogenous superoxide-dependent cytotoxicity, including the products of activated macrophages. Further work will address the role of the Cu,Zn SOD during infection within the host and how the SOD activity derived from sodC relates to the Mn,Fe SOD in M. tuberculosis.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grants AI40075 (to N.A.B.), AI39557 and AI44486 (to F.C.F.), and AI40488 (to I.A.O.) and by a Research Training Fellowship from the American Lung Association of California (to D.L.P.).
We thank Joshua Fierer for the gift of the
gp91phox
/
mice and Stewart Cole for
cosmid Y22G10.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0640. Phone: (858) 534-6024. Fax: (858) 534-6020. E-mail: nbuchmeier{at}ucsd.edu.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Absolom, D. 1986. Basic methods for the study of phagocytosis. Methods Enzymol. 132:95-180[Medline]. |
| 2. | Adams, L. B., M. Dinauer, D. Morgenstern, and J. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246[CrossRef][Medline]. |
| 3. |
Archibald, F., and M. Duong.
1986.
Superoxide dismutase and oxygen toxicity defenses in the genus Neisseria.
Infect. Immun.
51:631-641 |
| 4. | Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64-76[CrossRef][Medline]. |
| 5. | Bryk, R., P. Griffin, and C. Nathan. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407:211-215[CrossRef][Medline]. |
| 6. | Buchmeier, N., A. Blanc-Potard, S. Ehrt, D. Piddington, L. Riley, and E. Groisman. 2000. A parallel intraphagosomal survival strategy shared by Mycobacterium tuberculosis and Salmonella enterica. Mol. Microbiol. 35:1375-1382[CrossRef][Medline]. |
| 7. | Canvin, J., P. Langford, K. Wilks, and J. Kroll. 1996. Identification of sodC encoding periplasmic [Cu, Zn]-superoxide dismutase in Salmonella. FEMS Microbiol. Lett. 136:215-220[CrossRef][Medline]. |
| 8. |
Chan, J.,
X. Fan,
S. Hunter,
P. Brennan, and B. Bloom.
1991.
Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages.
Infect. Immun.
59:1755-1761 |
| 9. | Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544[CrossRef][Medline]. |
| 10. |
Cooper, A. M.,
B. Segal,
A. Frank,
S. Holland, and I. Orme.
2000.
Transient loss of resistance to pulmonary tuberculosis in p47phox / mice.
Infect. Immun.
68:1231-1234 |
| 11. |
De Groote, M. A.,
U. A. Ochsner,
M. U. Shiloh,
C. Nathan,
J. M. McCord,
M. Dinauer,
S. J. Libby,
A. Vazquez-Torres,
Y. Xu, and F. C. Fang.
1997.
Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase.
Proc. Natl. Acad. Sci. USA
94:13997-14001 |
| 12. | Ding, A., C. Nathan, and D. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:2407-2412[Abstract]. |
| 13. |
Dussurget, O.,
G. Stewart,
O. Neyrolles,
P. Pescher,
D. Young, and G. Marchal.
2001.
Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase.
Infect. Immun.
69:529-533 |
| 14. |
Fang, F. C.,
M. DeGroote,
J. Foster,
A. Baumler,
U. Ochsner,
T. Testerman,
S. Bearson,
J. Giard,
Y. Xu,
G. Campbell, and T. Laessig.
1999.
Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases.
Proc. Natl. Acad. Sci. USA
96:7502-7507 |
| 15. |
Farr, S.,
D. Natvig, and T. Kogoma.
1985.
Toxicity and mutagenicity of plumbagin and the induction of a possible new DNA repair pathway in Escherichia coli.
J. Bacteriol.
164:1309-1316 |
| 16. | Farrant, J., A. Sansone, J. Canvin, M. Pallen, P. Langford, T. Wallis, G. Dougan, and J. S. Kroll. 1997. Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol. Microbiol. 25:785-796[CrossRef][Medline]. |
| 17. | Gort, A. S., D. Ferber, and J. Imlay. 1999. The regulation and role of the periplasmic copper, zinc superoxide dismutase of Escherichia coli. Mol. Microbiol. 32:179-191[CrossRef][Medline]. |
| 18. |
Harth, G., and M. A. Horwitz.
1999.
Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery.
J. Biol. Chem.
274:4281-4292 |
| 19. | Jacob, C., A. Pastorino, A. Azavedo, H. Marques, H. Sato, L. Ferrazole, M. Aquino, P. Sakane, and A. Grumach. 1996. Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants. J. Investig. Allergol. Clin. Immunol. 6:202-206[Medline]. |
| 20. | Jacobs, W. R., Jr., G. V. Kalpana, J. D. Cirillo, L. Pascopella, S. B. Snapper, R. A. Udani, W. Jones, R. G. Barletta, and B. R. Bloom. 1991. Genetic systems for mycobacteria. Methods Enzymol. 204:537-555[Medline]. |
| 21. | Kim, B., M. Han, and A. Chung. 2001. Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells. Free Radical Biol. Med. 30:686-698[CrossRef][Medline]. |
| 22. | Latimer, E., J. Simmers, N. Sriranganathan, R. Roop, G. Schurig, and S. Boyle. 1992. Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice. Microb. Pathog. 12:105-113[CrossRef][Medline]. |
| 23. | Lau, Y., G. Chan, Y. Hui, and K. Yuen. 1998. The role of the phagocytic burst in host defense against Mycobacterium tuberculosis. Clin. Infect. Dis. 26:226-227[Medline]. |
| 24. |
Laubach, V. E.,
E. G. Shesely,
O. Smithies, and P. A. Sherman.
1995.
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
Proc. Natl. Acad. Sci. USA
92:10688-10692 |
| 25. |
Liochev, S. I., and I. Fridovich.
1994.
The role of O2. in the production of HO.: in vitro and in vivo.
Free Radical Res.
16:29-33.
|
| 26. |
Manca, C.,
S. Paul,
C. E. Barry III,
V. H. Freedman, and G. Kaplan.
1999.
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro.
Infect. Immun.
67:74-79 |
| 27. | Miller, R., and B. Britigan. 1997. Role of oxidants in microbial pathophysiology. Clin. Microbiol. Rev. 10:1-18[Abstract]. |
| 28. | Mouy, R., A. Fischer, E. Vilmer, R. Seger, and C. Griscelli. 1989. Incidence, severity and prevention of infections in chronic granulomatous disease. J. Pediatr. 114:555-560[CrossRef][Medline]. |
| 29. |
Nathan, C., and M. Shiloh.
2000.
Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens.
Proc. Natl. Acad. Sci. USA
97:8841-8848 |
| 30. |
Pacelli, R.,
D. Wink,
J. Cook,
M. Krishna,
W. DeGraff,
N. Friedman,
M. Tsokos,
A. Samuni, and J. Mitchell.
1995.
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli.
J. Exp. Med.
182:1469-1479 |
| 31. | Pollock, J. D., D. A. Williams, M. A. C. Gifford, L. Li, X. Du, J. Fisherman, S. Orkin, C. Doerschik, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209[CrossRef][Medline]. |
| 32. | Rouse, D., J. A. DeVito, Z. Li, H. Byer, and S. L. Morris. 1996. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol. Microbiol. 22:583-592[CrossRef][Medline]. |
| 33. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 34. |
San Mateo, L.,
K. Toffer,
P. Orndorff, and T. Kawula.
1999.
Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.
Infect. Immun.
67:5345-5351 |
| 35. |
Sheehan, B.,
P. Langford,
A. Rycroft, and J. S. Kroll.
2000.
[Cu,Zn]-superoxide dismutase mutants of the swine pathogen Actinobacillus pleuropneumoniae are unattenuated in infections of the natural host.
Infect. Immun.
68:4778-4781 |
| 36. |
St. John, G., and H. Steinman.
1996.
Periplasmic copper-zinc superoxide dismutase of Legionella pneumophila: role in stationary-phase survival.
J. Bacteriol.
178:1578-1584 |
| 37. |
Stuehr, D. J., and M. Marletta.
1985.
Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to E. coli lipopolysaccharide.
Proc. Natl. Acad. Sci. USA
82:7738-7742 |
| 38. |
Tatum, F.,
P. Detilleux,
J. Sacks, and S. Hallig.
1992.
Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.
Infect. Immun.
60:2863-2869 |
| 39. |
Teixeira, H. D.,
R. Schumacher, and R. Meneghini.
1998.
Lower intracellular hydrogen peroxide levels in cells overexpressing CuZn-superoxide dismutase.
Proc. Natl. Acad. Sci. USA
95:7872-7875 |
| 40. | Wengenack, N. L., M. P. Jensen, F. Rusnak, and M. K. Stern. 1999. Mycobacterium tuberculosis KatG is a peroxynitritase. Biochem. Biophys. Res. Commun. 256:485-487[CrossRef][Medline]. |
| 41. |
Wilks, K.,
K. Dunn,
J. Farrant,
K. Reddin,
A. Gorringe,
P. Langford, and J. S. Kroll.
1998.
Periplasmic superoxide dismutase in meningococcal pathogenicity.
Infect. Immun.
66:213-217 |
| 42. | Wu, C. H. H., J. Tsai-Wu, Y. Huang, C. Lin, G. Lioua, and F. Lee. 1998. Identification and subcellular localization of a novel Cu, Zn superoxide dismutase of Mycobacterium tuberculosis. FEBS Lett. 439:192-196[CrossRef][Medline]. |
| 43. | Yu, K., C. Mitchell, Y. Xing, R. Magliozzo, B. Bloom, and J. Chan. 1999. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber. Lung Dis. 79:191-198[CrossRef][Medline]. |
| 44. | Zhang, Y., R. Lathigra, T. Garbe, D. Catty, and D. Young. 1991. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol. Microbiol. 5:381-391[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»